ZLTQ ZELTIQ Aesthetics Inc

ZELTIQ AESTHETICS (ZLTQ) SHAREHOLDER ALERT – Andrews & Springer LLC is Investigating ZELTIQ Aesthetics, Inc. for Potential Breaches of Fiduciary Duty

WILMINGTON, Del.--(BUSINESS WIRE)--

Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty and securities violation claims against ZELTIQ Aesthetics, Inc. (NASDAQGS:ZLTQ) (“ZELTIQ” or the “Company”).

If you currently own shares of ZELTIQ and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/zeltiq-aesthetics-class-action-investigation/ or contact Craig J. Springer, Esq. at [email protected], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.

Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute. For more information please visit our website at www.andrewsspringer.com. This notice may constitute Attorney Advertising.

EN
13/03/2017

Underlying

ZLTQZELTIQ Aesthetics Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZELTIQ Aesthetics Inc

 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into ...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ) stock prior to February 12, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of ZELTIQ to Allergan plc (NYSE:AGN) for $56.50 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/zeltiq or contact Joseph E. Levi, Esq. eithe...

March 13, 2017 1 EN
 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

ZELTIQ AESTHETICS (ZLTQ) SHAREHOLDER ALERT – Andrews & Springer LLC ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty and securities violation claims against ZELTIQ Aesthetics, Inc. (NASDAQGS:ZLTQ) (“ZELTIQ” or the “Company”). If you currently own shares of ZELTIQ and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/zeltiq-aesthe...

March 13, 2017 1 EN
 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Propo...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ) (“ZELTIQ” or the “Company”) relating to the proposed buyout of ZELTIQ by Allergan plc. Under the terms of the agreement, ZELTIQ shareholders are anticipated to receive $56.50 in cash for each share of ZELTIQ common stock held. The firm’s inves...

February 16, 2017 1 EN
 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

ZELTIQ AESTHETICS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie ...

DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of ZELTIQ Aesthetics, Inc. (“ZELTIQ”) (NasdaqGS: ZLTQ) concerning the acquisition by Allergan plc. Under the terms of the agreement, valued at approximately $2.48 billion, ZELTIQ shareholders will only receive $56.50 per ZELTIQ share owned. The consideration is significantly lower than at least one analyst’s estimated value of $58.00 per share. If you...

February 14, 2017 1 EN
 PRESS RELEASE
Free
ZLTQ ZELTIQ Aestheti...

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ) (“ZELTIQ” or the “Company”) relating to the proposed buyout of ZELTIQ by Allergan plc. Under the terms of the agreement, ZELTIQ shareholders are anticipated to receive $56.50 in cash for each share of ZELTIQ common stock held. The firm’s inves...

February 14, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch